This Week’s Life Science Headlines January 16, 2014 / Class Action FDA Litigation News Pharmaceuticals Product Liability Recalls Regulatory / Life Science Matters Litigation Roche Loses Last Shot at Booting NJ Accutane Judge (subscription required) NuvaRing Lawsuits Remain on Hold, as Trial Date Cancelled Pfizer Faces Whistleblower Suit Over Lipitor Marketing (subscription required) Forest Can’t Nix Mo. Class In Antidepressant Marketing MDL (subscription required) Third Bellwether Trial in Bard Avaulta Mesh Litigation Delayed Indefinitely 8th Circ. Affirms Novartis Loss in Aredia, Zometa Suit (subscription required) NJ High Court Stays Accutane Case, Weighs Judge’s Recusal (subscription required) Regulatory FDA to Reopen Comment Period on the Cosmetics and Foods Portions of its Guidance on Determining if Human Research Studies Require an Investigational New Drug Application FDA Statement – Recommendation to Discontinue Prescribing and Dispensing 325 mg Acetaminophen Prescription Draft Guidance: Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media For Prescription Human and Animal Drugs and Biologics New Beverage Guidelines Say Some Supplement Additives Fall Under FDA Blood Glucose Meter Problems May Lead to New FDA Guidelines FDA Gives Drugmakers Taste of Social Media Rules (subscription required) FDA Pushes Hospitals to Buy from Registered Compounders (subscription required) Recalls Liptruzet Recall Issued for All Lots of Combination Cholesterol Drug Tandem t:cell Insulin Cartridge Recall Issued Over Leaks Puritan Bennett 840 Series Ventilator I Recall – Software Problem For a look at last week’s life science headlines, click here. Life Science Matters
This Week’s Life Science Headlines
Litigation
Regulatory
Recalls
For a look at last week’s life science headlines, click here.
Life Science Matters
Next ArticleClaims Regarding Post-FDA Approval Problems Not Preempted